HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Deng, W. Articles by Kadowitz, P. J. Search for Related Content PubMed PubMed Citation Articles by Deng, W. Articles by Kadowitz, P. J.

Engineering Ex Vivo–Expanded Marrow Stromal Cells to Secrete Calcitonin Gene–Related Peptide Using Adenoviral Vector

^a Departments of Pharmacology,
^b Urology, and
^c Structural and Cellular Biology, Tulane University Health Sciences Center, New Orleans, Louisiana, USA

Key Words. Marrow stromal cells • Calcitonin gene–related peptide • Adenovirus • Gene expression • Differentiation • Gene therapy

Correspondence: Philip J. Kadowitz, Ph.D., Department of Pharmacology, SL83, Tulane University Health Sciences Center, 1430 Tulane Avenue, New Orleans, Louisiana 70112, USA. Telephone: 504-584-2637; Fax: 504-588-5283; e-mail: pkad-owi{at}tulane.edu

Calcitonin gene–related peptide (CGRP) is a target for cardiovascular gene therapy. Marrow stromal cells (MSCs) hold promise for use in adult stem cell–based cell and gene therapy. To determine the feasibility of adenoviral-mediated CGRP gene transfer into ex vivo–expanded MSCs, rat MSCs were isolated, ex vivo expanded, and transduced with adenoviruses. Adprepro-CGRP and AdntlacZ, adenoviral vectors containing prepro-CGRP or nuclear-targeted ß-galactosidase reporter gene ntlacZ under the control of Rous sarcoma virus promoter, were used. In this study, it can be shown that transduction efficiency of adenoviral-mediated gene transfer into ex vivo–expanded MSCs is dose dependent, transgene expression persists for more than 21 days in culture, and adenoviral transduction does not alter the proliferation or viability of MSCs. Transduced MSCs retain multipotentiality and transgene expression after cell differentiation. The expression and secretion of CGRP by Adprepro- CGRP–transduced MSCs was confirmed by Western blot analysis and enzyme immunoassay. The secretion of CGRP by Adprepro-CGRP–transduced MSCs is dose dependent, and the transduced cells release as much as 9.5 ± 0.4 pmol CGRP/1 x 10⁶ cells/48 hours (mean ± standard error of mean, n = 3) into culture medium at a multiplicity of infection of 300. Furthermore, culture supernatant from Adprepro-CGRP–transduced MSCs increases intracellular cyclic AMP levels in pulmonary artery smooth muscle cells in culture. These findings suggest that replication-deficient recombinant adenovirus can be used to gene engineer ex vivo–expanded MSCs and that high-level secretion of biologically active CGRP can be achieved, underscoring the clinical potential of using this novel adult stem cell–based cell and gene therapy strategy for the treatment of cardiovascular diseases.

This article has been cited by other articles:

				T. J. Bivalacqua, W. Deng, M. Kendirci, M. F. Usta, C. Robinson, B. K. Taylor, S. N. Murthy, H. C. Champion, W. J. G. Hellstrom, and P. J. Kadowitz Mesenchymal stem cells alone or ex vivo gene modified with endothelial nitric oxide synthase reverse age-associated erectile dysfunction Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1278 - H1290. [Abstract] [Full Text] [PDF]

				L. G. Menon, S. Picinich, R. Koneru, H. Gao, S. Y. Lin, M. Koneru, P. Mayer-Kuckuk, J. Glod, and D. Banerjee Differential Gene Expression Associated with Migration of Mesenchymal Stem Cells to Conditioned Medium from Tumor Cells or Bone Marrow Cells Stem Cells, February 1, 2007; 25(2): 520 - 528. [Abstract] [Full Text] [PDF]